Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barton F Haynes

Showing results (71-80 of 552) with videos related to

Pageof 56
Sort By:
AIDS Research and Human Retroviruses|August 24, 2004
An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120S Munir Alam, Casey A Paleos, Hua-Xin Liao, et al.
Journal of Proteome Research|January 24, 2013
Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteinsEden P Go, Hua-Xin Liao, S Munir Alam, et al.
BMC Immunology|September 29, 2022
Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapyJustin Pollara, Santosh Khanal, R Whitney Edwards, et al.
Science Translational Medicine|October 23, 2015
Immune correlates of vaccine protection against HIV-1 acquisitionLawrence Corey, Peter B Gilbert, Georgia D Tomaras, et al.
Nature Reviews. Drug Discovery|October 12, 2016
Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infectionGuido Ferrari, Barton F Haynes, Scott Koenig, et al.
Cell Reports|February 16, 2017
BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell ToleranceMasayuki Kuraoka, Pilar B Snowden, Takuya Nojima, et al.
Expert Review of Vaccines|August 3, 2004
Centralized immunogens as a vaccine strategy to overcome HIV-1 diversityFeng Gao, Bette T Korber, Eric Weaver, et al.
Journal of Virology|December 14, 2011
High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infectionChristy L Lavine, Socheata Lao, David C Montefiori, et al.
International Journal of Mass Spectrometry|August 24, 2011
Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine CandidateEden P Go, Geetha S Hewawasam, Ben J Ma, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodiesMikyung Kim, Zhi-Song Qiao, David C Montefiori, et al.
Pageof 56

Showing results (71-80 of 552) with videos related to

Sort By:
Pageof 56
AIDS Research and Human Retroviruses|August 24, 2004
An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120S Munir Alam, Casey A Paleos, Hua-Xin Liao, et al.
Journal of Proteome Research|January 24, 2013
Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteinsEden P Go, Hua-Xin Liao, S Munir Alam, et al.
BMC Immunology|September 29, 2022
Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapyJustin Pollara, Santosh Khanal, R Whitney Edwards, et al.
Science Translational Medicine|October 23, 2015
Immune correlates of vaccine protection against HIV-1 acquisitionLawrence Corey, Peter B Gilbert, Georgia D Tomaras, et al.
Nature Reviews. Drug Discovery|October 12, 2016
Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infectionGuido Ferrari, Barton F Haynes, Scott Koenig, et al.
Cell Reports|February 16, 2017
BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell ToleranceMasayuki Kuraoka, Pilar B Snowden, Takuya Nojima, et al.
Expert Review of Vaccines|August 3, 2004
Centralized immunogens as a vaccine strategy to overcome HIV-1 diversityFeng Gao, Bette T Korber, Eric Weaver, et al.
Journal of Virology|December 14, 2011
High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infectionChristy L Lavine, Socheata Lao, David C Montefiori, et al.
International Journal of Mass Spectrometry|August 24, 2011
Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine CandidateEden P Go, Geetha S Hewawasam, Ben J Ma, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodiesMikyung Kim, Zhi-Song Qiao, David C Montefiori, et al.
Pageof 56